for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-CSPC Pharmaceutical Group's Gastric Cancer Drug Granted Orphan-Drug Designation By U.S. FDA​

Feb 6 (Reuters) - CSPC Pharmaceutical Group Ltd:

* GROUP’S GASTRIC CANCER DRUG “DP303C” WAS GRANTED ORPHAN-DRUG DESIGNATION BY U.S. FDA Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up